OR WAIT null SECS
SYDNEY, Australia -- Unitract Ltd. announces that its advanced syringe technology has been honored with two distinguished awards for innovation at the 32nd International Exhibition of Inventions and New Technologies in Geneva.
The awards are widely regarded as the key annual event to recognize the
world's best new inventions. This year, a record 675 inventions from 42
countries were exhibited and judged before an array of international
specialists. The inventions were also viewed by more than 60,000 visitors, of
which more than half were reported to be industrialists, distributors and
businessmen seeking to invest and market new inventions.
Unitract was presented with the prestigious Prize of the State of Geneva
Award, which is given by the host city to the invention they consider having
the greatest potential for commercial success, as well as its overall benefit
to humanity. The Unitract Syringe also received a Gold Medal for Best Medical
Device, which in itself is a significant tribute for an Australian innovation.
Alan Shortall, chief executive of Unitract Ltd, said the company was
honored to receive such global endorsement of its technology. "The State of Geneva Award is one of the greatest possible endorsements
Unitract could ever hope to receive. It is a recognition and validation of our
technology on a truly international stage from some of the world's most
brilliant minds. The Gold Medal for Best Medical Device is also very special,
considering the high level of competition which existed in the category this
"Unitract must especially congratulate its joint heads of research and
development, Craig Thorley and Joe Kaal, for the development of the syringe's
core technology. These awards are a particular testament to the drive,
dedication and ingenuity which they displayed in developing the next
generation of syringe technology," Shortall added.
The Unitract Syringe is designed to automatically help prevent both needlestick injuries and the reuse of syringes. Together these two unsafe injection practices kill more than
1.3 million people a year via the transmission of bloodborne diseases including HIV-AIDS, Hepatitis B and Hepatitis C.
Source: Unitract Ltd.